Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 24721-24730 Newer>

The Motley Fool July 23, 2007 Tom Taulli	Airvana Is Oxygen-Deprived Even though Airvana has spent nearly $200 million developing its products and is addressing a growth market, the company faces some major challenges. It's got Wall Street concerned, and investors should be cautious as well.
The Motley Fool July 23, 2007 Nathan Parmelee	Quick Take: Barclays Plays the China Card China Development Bank and Temasek help with Barclays' bid for ABN. Investors, take note.
The Motley Fool July 23, 2007 Brian Lawler	GPC's Date With the FDA A document released by the FDA outlines its concerns with GPC's lead drug. Investors, take note.
The Motley Fool July 23, 2007 Brian Orelli	A Bright Future for Ventana Ventana Medical Systems reported second-quarter earnings on Thursday afternoon, but it was the future earnings prediction that made it happy day for investors.
The Motley Fool July 23, 2007 Rich Smith	Foolish Forecast: EMC = Q1 The data company is set to report first-quarter earnings shortly. Investors, here is what you expect to see.
The Motley Fool July 23, 2007 Brian Lawler	Progenics Gets Back In the Game Being the first approved to market an oral compound to treat one of the more painful side effects from opioid use will be a boon to whichever drugmaker can reach this goal. With the competitior Adolor looking more likely to be out of this race, Progenics is in the pole position once again.
The Motley Fool July 23, 2007 Rick Aristotle Munarriz	3 Stocks That Blew the Market Away Beat the market and the world will beat a path to your door. Intel... TD Ameritrade... eBay...
The Motley Fool July 23, 2007 Rick Aristotle Munarriz	4 Stocks That Took a Hike Companies with growing yields can make you rich in more ways than the obvious. CARBO Ceramics... Fannie Mae... Renaissance Learning... Burlington Northern Santa Fe...
The Motley Fool July 23, 2007 Tom Taulli	The Rupee Raps Wipro External cost pressures dragged on the Indian consulting firm's first-quarter results. Investors, take note.
The Motley Fool July 23, 2007 Ryan Fuhrmann	Wachovia Is One Big Deal Wachovia snapped up one rival and is still digesting another. Investors, take note.
<Older 24721-24730 Newer> Return to current articles.